Amirul Haziq

Amirul is building OncoTrace.

We are developing an AI-powered lung cancer early detection platform built for hospitals and clinics. Instead of waiting for symptoms, we use a simple blood draw and our system analyzes trace elements in the sample and an AI model tells the clinician whether the patient is low, medium, or high risk for lung cancer. The science is done. We have a working prototype, 86.3% model accuracy, and two patents filed. What we're building now is the infrastructure to take it out of the lab like cloud platform, hospital integration, and a path to clinical deployment across Malaysia and Southeast Asia.